Is this the world’s best cancer doctor? Houston oncologist developed cutting-edge treatment for disease that sees 50% of patients achieve complete remission, with sufferers flocking to him from all over the world

Cancer patients have flocked from around the world to a Houston oncologist who has developed a cutting-edge treatment that achieves a complete remission in 50 percent of patients.

Philip Salem, 82, combined immunotherapy, chemotherapy and targeted therapy to create a breakthrough cancer treatment called ICTriplex at his Salem Oncology Center.

‘I have been in cancer medicine for 55 years. I have never seen before what I am seeing now because of ICTriplex,” said Salem ABC7.

The 82-year-old oncologist, at the forefront of cancer research, has his findings in the American Society of Clinical Oncology Journal in June 2022.

The compelling outcomes of his study drew desperate patients from around the world, who traveled thousands of miles to Houston, Texas, in search of hope and the possibilities offered by this groundbreaking treatment.

Cancer patients flocked from around the world to a Houston oncologist, Philip Salem, who developed a cutting-edge treatment that saw 50 percent of patients achieve complete remission

Cancer patients flocked from around the world to a Houston oncologist, Philip Salem, who developed a cutting-edge treatment that saw 50 percent of patients achieve complete remission

Salem, 82, combined immunotherapy, chemotherapy and targeted therapy to create a breakthrough cancer treatment called ICTriplex

Salem, 82, combined immunotherapy, chemotherapy and targeted therapy to create a breakthrough cancer treatment called ICTriplex

Petra, a cancer patient who called the treatment a miracle, said: 'I was in a lot of pain at the beginning when I came here, and in the first month it was already gone'

Petra, a cancer patient who called the treatment a miracle, said: ‘I was in a lot of pain at the beginning when I came here, and in the first month it was already gone’

Bianca Gurrado, a patient who traveled from Italy to Houston, said that she first heard from Dr. about a year ago. Salem learned when her cancer progressed and spread.

“I did start therapy in Italy, but unfortunately the results of the therapy were not good, so I was in constant progression of the disease.”

Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said.

Petra, a cancer patient who called the treatment a miracle, said: ‘I had a lot of pain in the beginning when I came here, and in the first month it was already gone.’

Salem’s oncology center is the only facility that uses the combination of immunotherapy, chemotherapy and targeted therapy to manage advanced cancer, the doctor said.

“We’ve taken patients who were told by major cancer centers to go home and die, and we’ve had a 50 to 60 percent complete remission rate.”

“Zero percent versus 50 percent, it’s an easy choice,” said cancer patient Marco Praagman.

Bianca Gurrado, a patient who traveled from Italy to Houston, said that she first heard from Dr. about a year ago.  Salem learned when her cancer progressed and spread

Bianca Gurrado, a patient who traveled from Italy to Houston, said that she first heard from Dr. about a year ago. Salem learned when her cancer progressed and spread

Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said

Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said

Salem’s research on ICTriplex was published in the American Society of Clinical Oncology Journal, one of the most influential journals in the field.

He studied 41 patients with various types of cancer, including lung, pancreatic, colorectal, breast, all of which were at an advanced stage of progression.

The total remission rate, considering patients in both partial remission and complete remission, was an impressive 90 percent.

In contrast, conventional treatments typically achieve a remission rate of less than 30 percent, he said.

He told Houston Chronicle in 2022: ‘And, to our surprise, this combination appears to be very effective in a wide spectrum of cancer diagnosis. It does not limit it to one diagnosis or to one tumor.’

The ground-breaking treatment was more effective in patients with lung and pancreatic cancer, with a complete remission rate of 70 percent.

Salem said, “We recommend the treatment as a front line, as the first line of therapy, because it was very effective in the lung and the pancreas.”

“Zero percent versus 50 percent, it’s an easy choice,” said cancer patient Marco Praagman

Salem studied 41 patients with various types of cancer, including lung, pancreatic, colorectal, breast, all of which were at an advanced stage of progression.

Salem studied 41 patients with various types of cancer, including lung, pancreatic, colorectal, breast, all of which were at an advanced stage of progression.

Patients are grateful to Salem and recognize him as a beacon of hope as they battled what is often considered the most difficult disease in the human world.

Ellie Moore, who was diagnosed with stage 4 lung cancer a decade ago, has been in remission since 2019.

“I knew I had to do everything I could to fight and Dr. Salem assured me that we would not give up,” she said.

“Since I live in Houston, I was able to leave my office to receive treatment and then return to work the same day,” she added.

‘I love Dr. Salem; he is my hero,” Gurrado said with genuine happiness.